HomeAVBP • NASDAQ
add
Arrivent Biopharma Inc
Previous close
$21.17
Day range
$20.41 - $21.00
Year range
$15.36 - $36.20
Market cap
708.22M USD
Avg Volume
239.76K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
The Motley Fool
5 minutes ago
Should You Buy the Highest-Yielding Dow Stock After the Market Sell-Off?
0.050%
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 23.70M | 2.54% |
Net income | -20.63M | 2.64% |
Net profit margin | — | — |
Earnings per share | -0.61 | 98.02% |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 218.86M | 45.53% |
Total assets | 274.94M | 68.57% |
Total liabilities | 17.29M | 46.50% |
Total equity | 257.65M | — |
Shares outstanding | 34.02M | — |
Price to book | 2.77 | — |
Return on assets | -20.88% | — |
Return on capital | -22.13% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | -20.63M | 2.64% |
Cash from operations | -16.15M | -8.31% |
Cash from investing | -192.46M | -869.86% |
Cash from financing | 55.00K | 105.20% |
Net change in cash | -208.56M | -2,409.66% |
Free cash flow | -10.33M | -19.28% |
About
Founded
2021
Headquarters
Website
Employees
52
